Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Gilead Sciences, Inc. (NASDAQ: GILD) closed the day trading at $67.55 up 1.29% from the previous closing price of $66.69. In other words, the price has increased by $1.29 from its previous closing price. On the day, 5.75 million shares were traded. GILD stock price reached its highest trading level at $68.18 during the session, while it also had its lowest trading level at $67.035.
Ratios:
For a better understanding of GILD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.65. For the most recent quarter (mrq), Quick Ratio is recorded 0.94 and its Current Ratio is at 1.08. In the meantime, Its Debt-to-Equity ratio is 1.44 whereas as Long-Term Debt/Eq ratio is at 1.23.
On May 01, 2024, Maxim Group reiterated its Buy rating and also upped its target price recommendation from $90 to $85.
HSBC Securities Upgraded its Reduce to Hold on April 24, 2024, while the target price for the stock was maintained at $69.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’24 when Parsey Merdad sold 2,000 shares for $68.63 per share. The transaction valued at 137,260 led to the insider holds 96,380 shares of the business.
GILEAD SCIENCES, INC. bought 485,250 shares of GILD for $368,790 on Apr 02 ’24. The 10% Owner now owns 7,345,473 shares after completing the transaction at $0.76 per share. On Apr 01 ’24, another insider, Parsey Merdad, who serves as the Chief Medical Officer of the company, sold 2,000 shares for $72.96 each. As a result, the insider received 145,920 and left with 96,304 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GILD now has a Market Capitalization of 84157169664 and an Enterprise Value of 103743381504. As of this moment, Gilead’s Price-to-Earnings (P/E) ratio for their current fiscal year is 188.32, and their Forward P/E ratio for the next fiscal year is 9.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 34.97. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.07 while its Price-to-Book (P/B) ratio in mrq is 4.80. Its current Enterprise Value per Revenue stands at 3.779 whereas that against EBITDA is 8.191.
Stock Price History:
The Beta on a monthly basis for GILD is 0.20, which has changed by -0.112585366 over the last 52 weeks, in comparison to a change of 0.2553556 over the same period for the S&P500. Over the past 52 weeks, GILD has reached a high of $87.86, while it has fallen to a 52-week low of $62.07. The 50-Day Moving Average of the stock is 2.15%, while the 200-Day Moving Average is calculated to be -8.38%.
Shares Statistics:
Over the past 3-months, GILD traded about 7.65M shares per day on average, while over the past 10 days, GILD traded about 6692940 shares per day. A total of 1.25B shares are outstanding, with a floating share count of 1.24B. Insiders hold about 0.09% of the company’s shares, while institutions hold 85.65% stake in the company. Shares short for GILD as of 1718323200 were 18806316 with a Short Ratio of 2.46, compared to 1715731200 on 21700643. Therefore, it implies a Short% of Shares Outstanding of 18806316 and a Short% of Float of 1.50999995.
Dividends & Splits
GILD’s forward annual dividend rate is 3.04, up from 3.02 a year ago. Against a Trailing Annual Dividend Yield of 0.04528415The stock’s 5-year Average Dividend Yield is 4.03. The current Payout Ratio is 66.62% for GILD, which recently paid a dividend on 2024-06-14 with an ex-dividend date of 1718323200. Stock splits for the company last occurred on 2013-01-28 when the company split stock in a 2:1 ratio.
